Effect of MN705 treatment on TGF- by Wencheng Jin (13136262)

Subjects:

The screening process of MN705. by Wencheng Jin (13136262)

Subjects:

Changes associated with kidney fibrosis and effects of MN705 treatment on TGF- by Wencheng Jin (13136262)

Subjects:

Novel chromobox 2 inhibitory peptide decreases tumor progression by Lindsay W. Brubaker (15099942)

shRNA-mediated knockdown of SNAP23 decreases expression of KCa2.3 in HeLa cells. by Claudia A. Bertuccio (309866)

“…Knockdown of SNAP23 resulted in a decrease in both PM expression of KCa2.3 (top blot and panel <b>(B)</b>), as well as total KCa2.3 (middle blot and panel <b>(C)</b>). …”

PI+ total immune cells are decreased at days 2, 5, and 14 following IR, and PI+ neutrophils are increased at day 30. by Jordan A. Gunning (18143970)

A low dose of BTZ decreases proteasome activity with no effect on cell viability. by A. L. Furfaro (2587792)

Ligand-Controlled Magnetic Interactions in Mn₄ Clusters by Erik Kampert (2330428)

“…Experimentally measured magnetic moments in high magnetic fields show that, upon electron density withdrawal, the main antiferromagnetic exchange constant <i>J</i>₁ decreases from −2.2 K for the [Mn₄(OAc)₄] cluster to −1.9 K for the [Mn₄(H₅C₆COO)₄] cluster and −0.6 K for the [Mn₄(F₃CCOO)₄] cluster, while <i>J</i>₂ decreases from −1.1 K to nearly 0 K and <i>J</i>₃ changes to a small ferromagnetic coupling. …”

Ligand-Controlled Magnetic Interactions in Mn₄ Clusters by Erik Kampert (2330428)

“…Experimentally measured magnetic moments in high magnetic fields show that, upon electron density withdrawal, the main antiferromagnetic exchange constant <i>J</i>₁ decreases from −2.2 K for the [Mn₄(OAc)₄] cluster to −1.9 K for the [Mn₄(H₅C₆COO)₄] cluster and −0.6 K for the [Mn₄(F₃CCOO)₄] cluster, while <i>J</i>₂ decreases from −1.1 K to nearly 0 K and <i>J</i>₃ changes to a small ferromagnetic coupling. …”

Imatinib decreases <i>in vivo</i> proliferation of T-cells. by Ludovic Belle (293091)

CC-1⁺ immunostained cell numbers decrease by 2 days after TBI and return to control levels by 5 weeks. by Krista A. Dent (709531)

“…Panels show contralateral (Contra) and ipsilateral (Ipsi) external capsule (EC) at (A,B) 2 days (2d), (C,D) 2 weeks (2w) and (E,F) 5 weeks (5w) (G) In the external capsule numbers of CC-1⁺ oligodendrocytes were decreased by 2d after injury, remained decreased at 2 weeks and returned to normal levels by 5 weeks. …”

Clinical characteristics. by Jesse A. Davidson (3158913)

Subjects:

13C5-adenosine production with ex vivo alkaline phosphatase supplementation. by Jesse A. Davidson (3158913)

Subjects:

Correlation of AP activity to 13C5-adenosine production pre-operation and prior to separation from cardiopulmonary bypass. by Jesse A. Davidson (3158913)

Subjects:

Pre-operation to rewarming change in alkaline phosphatase activity versus change in 13C5-adenosine with CD73 inhibition. by Jesse A. Davidson (3158913)

Subjects:

Pre-operation to rewarming change in alkaline phosphatase activity versus change in 13C5-adenosine without CD73 inhibition. by Jesse A. Davidson (3158913)

Subjects:

13C5-adenosine production without ectonucleotidase inhibition, with CD73 inhibition, and with alkaline phosphatase inhibition. by Jesse A. Davidson (3158913)

Subjects:

Adenosine production with AP supplementation + = significant at the 0.05 level adjusted for multiple comparisons. by Jesse A. Davidson (3158913)

Subjects:

Ratio of 13C5-adenosine production with and without CD73 inhibition, pre-operation and prior to separation from cardiopulmonary bypass. by Jesse A. Davidson (3158913)

Subjects:

Effect of an olive-oil bioactive extract on basal TEER (A) and TNF-α induced decrease in TEER (B) <i>in vitro</i>. by Martin Liehr (3863431)